Vitamin C was once the most hyped supplement in America, championed by a Nobel laureate who took 18 grams a day and promised it could cure everything from the common cold to cancer. That hype has largely faded, but the story of what happened to vitamin C is more nuanced than a simple debunking. The science kept going, and the answers got more complicated.
The Rise of Mega-Dosing
The vitamin C craze traces back almost entirely to one man: Linus Pauling, a chemist who had already won two Nobel Prizes when he published Vitamin C and the Common Cold in 1970. The book, written for a general audience, argued that massive doses of ascorbic acid could prevent and shorten colds. It was built largely on anecdotal evidence, but Pauling’s scientific reputation gave it enormous weight. Millions of Americans started popping vitamin C tablets.
Pauling kept escalating his claims. In 1979, he co-authored Cancer and Vitamin C, arguing the vitamin helped strengthen cells against cancer by building collagen and creating enzymes that protect healthy tissue. By 1993, he was taking 18 grams daily, the equivalent of roughly 360 oranges, and publicly crediting it with controlling his prostate cancer side effects during chemotherapy. He became the face of the mega-dose movement, and vitamin C became the bestselling supplement in the country.
What the Cold Research Actually Shows
Decades of clinical trials have now tested Pauling’s core claim. The most comprehensive analysis, a Cochrane review pooling 31 comparisons across nearly 10,000 cold episodes, found that taking vitamin C regularly does shorten colds, but modestly. In adults, cold duration dropped by about 8%. In children, the effect was stronger: a 14% reduction overall, and up to 18% when children took 1 to 2 grams daily. Regular supplementation also reduced the severity of symptoms, measured by fewer days stuck at home or off work and school.
The key word is “regular.” Taking vitamin C after you already feel a cold coming on doesn’t appear to help. The small benefit comes from having consistently higher levels in your system before you get sick. That’s a far cry from Pauling’s cure-all claims, but it’s not nothing, especially for kids or people under physical stress.
The Sepsis Disappointment
One of the biggest blows to the vitamin C revival came from critical care medicine. For years, some physicians championed intravenous vitamin C as a treatment for sepsis, a life-threatening response to infection that kills hundreds of thousands of people annually. Early, small studies looked promising enough to justify large trials.
The results were devastating. The LOVIT trial, published in the New England Journal of Medicine, randomized 872 patients in intensive care. Those receiving IV vitamin C fared worse, not better. Death or persistent organ dysfunction at 28 days occurred in 44.5% of the vitamin C group compared to 38.5% in the placebo group. Death alone trended higher too: 35.4% versus 31.6%. On every other measure, including organ function scores, kidney injury, and six-month survival, the two groups looked the same. The trial effectively closed the door on vitamin C as a sepsis treatment.
A Surprising Result in Pancreatic Cancer
While the sepsis story ended badly, cancer research has taken an unexpected turn. Researchers at the University of Iowa completed a phase 2 trial testing high-dose IV vitamin C alongside standard chemotherapy in patients with stage 4 metastatic pancreatic cancer, one of the deadliest diagnoses in medicine. The 34 patients who received both chemotherapy and vitamin C infusions survived an average of 16 months, compared to 8 months for those on chemotherapy alone. Progression-free survival extended from four months to six.
This is a small trial, and pancreatic cancer research has a long history of promising early results that don’t hold up in larger studies. But the doubling of survival time is striking enough that larger trials are being planned. The mechanism being investigated is different from what Pauling proposed: at very high intravenous doses, vitamin C appears to act as a pro-oxidant in tumor tissue rather than an antioxidant, essentially generating hydrogen peroxide that damages cancer cells while leaving healthy cells alone. This only works with IV delivery, not oral supplements.
Most Americans Don’t Get Enough
While the debate over mega-doses continues, there’s a quieter problem: a surprising number of Americans aren’t even hitting basic vitamin C levels. Analysis of national nutrition survey data found that about 42% of the U.S. population had insufficient blood levels of vitamin C. Within that group, 6% were outright deficient (low enough to risk scurvy-like symptoms), another 10% had levels considered dangerously low, and 26% fell into the inadequate range. The federal government hasn’t tracked the nation’s vitamin C status since 2006, so current numbers are unknown.
The recommended daily intake is 90 mg for men and 75 mg for women. Smokers need an extra 35 mg per day because tobacco use increases oxidative stress and depletes vitamin C from the blood and immune cells. A single orange provides roughly 70 mg, so meeting the baseline isn’t hard for people who eat fruits and vegetables regularly. But for those who don’t, supplementation at modest doses fills a real gap.
Kidney Stones and the Upper Limit
One reason the mega-dose era faded is growing evidence of real risks at high intakes. The body can only absorb so much vitamin C at once; excess is excreted, and some of it converts to oxalate in the kidneys. A metabolic study found that 2 grams daily increased urinary oxalate excretion by about 22%, and oxalate is the main component of the most common type of kidney stone.
Large cohort studies tracking tens of thousands of people found that the risk of kidney stones in men became statistically significant at total vitamin C intakes around 700 to 800 mg per day. Men taking 1,000 mg or more in supplements had a 19% higher risk. Interestingly, this association didn’t hold for women. Researchers now advise that men who have had calcium oxalate kidney stones avoid vitamin C supplements, though getting vitamin C from food doesn’t carry the same risk.
The Supplement Market Evolved
The vitamin C aisle looks very different from the Pauling era. Liposomal vitamin C, which wraps ascorbic acid in tiny fat-based capsules, has become a premium product with claims of superior absorption. A scoping review of the available studies found that liposomal formulations do reach higher peak blood levels than standard vitamin C, typically 1.2 to 5.4 times higher depending on the product. Some formulations showed total absorption up to 7 times greater.
Whether that matters for most people is another question. Your body tightly regulates vitamin C levels, and once your tissues are saturated, extra circulating vitamin C gets filtered out by the kidneys. Liposomal delivery is most relevant for people trying to push blood levels above what standard oral doses can achieve, which brings the kidney stone risk back into play.
Topical vitamin C has also become a staple in skincare. For it to actually penetrate the skin, formulations need to contain L-ascorbic acid at concentrations between 8% and 20%, at a pH below 3.5. Below 8%, it doesn’t do much. Above 20%, it causes irritation without additional benefit. The molecule is notoriously unstable in water, which is why effective products often include ferulic acid as a stabilizer, and why that serum in your medicine cabinet may have turned yellow or brown.
Where Things Stand Now
Vitamin C didn’t disappear. It lost its status as a miracle cure and settled into a more honest role. It modestly shortens colds if you take it consistently. It’s essential for immune function, wound healing, and collagen production. Tens of millions of Americans aren’t getting enough of it from food. And in one narrow, high-dose intravenous application, it may genuinely help certain cancer patients survive longer, though that story is still being written.
What “happened” to vitamin C is what happens to most overhyped health claims: the science caught up. It knocked down the biggest promises, confirmed some smaller ones, and revealed risks that the mega-dose enthusiasts never mentioned. The vitamin itself is as important as it ever was. The mythology around it is what faded.